###begin article-title 0
A Genetic Basis of Susceptibility to Acute Pyelonephritis
###end article-title 0
###begin p 1
Conceived and designed the experiments: CS AL MG GG BA SM. Performed the experiments: AL MG GG BR SM. Analyzed the data: CS AL MG GG BR MS BA SM. Contributed reagents/materials/analysis tools: IL CS AL MG GG LT BA DK CL JM UJ SM. Wrote the paper: CS AL BA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
For unknown reasons, urinary tract infections (UTIs) are clustered in certain individuals. Here we propose a novel, genetically determined cause of susceptibility to acute pyelonephritis, which is the most severe form of UTI. The IL-8 receptor, CXCR1, was identified as a candidate gene when mIL-8Rh mutant mice developed acute pyelonephritis (APN) with severe tissue damage.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 69 76 <span type="species:ncbi:9606">patient</span>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
###xml 344 352 <span type="species:ncbi:9606">children</span>
We have obtained CXCR1 sequences from two, highly selected APN prone patient groups, and detected three unique mutations and two known polymorphisms with a genotype frequency of 23% and 25% compared to 7% in controls (p<0.001 and p<0.0001, respectively). When reflux was excluded, 54% of the patients had CXCR1 sequence variants. The UTI prone children expressed less CXCR1 protein than the pediatric controls (p<0.0001) and two sequence variants were shown to impair transcription.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
The results identify a genetic innate immune deficiency, with a strong link to APN and renal scarring.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Sorensen1">[1]</xref>
###xml 185 188 185 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Chotivanich1">[2]</xref>
###xml 662 665 662 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hagberg1">[3]</xref>
###xml 667 670 667 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hang1">[5]</xref>
###xml 996 1001 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 466 469 <span type="species:ncbi:9606">man</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 748 754 <span type="species:ncbi:10090">murine</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
The genetic basis of susceptibility to common infectious diseases is largely not determined, except for one or two classical examples like malaria and hemoglobin A/E polymorphisms [1], [2]. Our laboratory has for many years been involved in an attempt to characterize the determinants of susceptibility to acute and chronic form of urinary tract infection (UTI) but so far, we and others have failed to identify genetic factors determining disease susceptibility in man. In an effort to characterize susceptibility mechanisms and gene(s) associated with particular infections, we have studied UTI susceptibility in "knock-out" mice with defects in specific loci [3], [5], . We have obtained evidence that the deletion of a single gene encoding the murine IL-8 chemokine receptor homologue (mIL-8Rh) precipitates the entire syndrome of acute pyelonephritis (APN) and renal scarring. In view of these findings, we have investigated whether genetic variability in the human chemokine receptor gene (CXCR1) might contribute to the disease incidence in APN-prone individuals.
###end p 9
###begin p 10
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Kunin1">[6]</xref>
###xml 162 165 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Stamm1">[7]</xref>
###xml 408 411 408 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Stamm1">[7]</xref>
###xml 413 416 413 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hodson1">[8]</xref>
###xml 418 421 418 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Ransley1">[9]</xref>
###xml 704 707 704 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hodson1">[8]</xref>
###xml 709 712 709 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Ransley1">[9]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lomberg1">[10]</xref>
###xml 848 864 848 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 968 972 968 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lomberg1">[10]</xref>
###xml 1057 1061 1057 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-SvanborgEdn1">[11]</xref>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus2">[12]</xref>
###xml 1131 1135 1131 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Bailey1">[13]</xref>
###xml 58 61 <span type="species:ncbi:9606">man</span>
###xml 682 690 <span type="species:ncbi:9606">patients</span>
###xml 848 864 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1053 1056 <span type="species:ncbi:9606">man</span>
UTIs are among the most prevalent bacterial infections in man and remain a significant concern due to their frequency and associated morbidity and mortality [6], [7]. Acute pyelonephritis (APN) is the most severe and rare form of UTI, and recurrent APN is clustered in a small group of highly susceptible individuals, some of whom develop progressive renal scarring and may need dialysis and transplantation [7], [8], [9]. There have been many attempts to identify the host factors, which predispose to UTI, and especially to APN. Mechanical dysfunctions like vesico-ureteric reflux increase the access of bacterial to the kidneys, but uro-dynamic abnormalities alone do not render patients prone to APN [8], [9], [10]. The P blood group and secretor state determine the mucosal repertoire of receptors for P fimbriae and help select the infecting Escherichia coli strain, but variant receptor expression does not influence the efficiency of the antibacterial defense [10]. Furthermore, Mendelian primary immuno-deficiencies do not predispose to UTI in man [11], [12] and attempts to relate the HLA antigen type to UTI have failed [13].
###end p 10
###begin p 11
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hagberg2">[14]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Svanborg1">[15]</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hang1">[4]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus2">[12]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Svensson1">[16]</xref>
###xml 476 479 476 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hang1">[4]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus2">[12]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Svensson1">[16]</xref>
###xml 641 644 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus1">[5]</xref>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Holmes1">[17]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Murphy1">[18]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Wolf1">[19]</xref>
###xml 951 954 951 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus1">[5]</xref>
###xml 1077 1081 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lundstedt1">[20]</xref>
###xml 170 176 <span type="species:ncbi:10090">murine</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 632 640 <span type="species:ncbi:9606">children</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
###xml 926 931 <span type="species:ncbi:9606">human</span>
The urinary tract relies on innate immunity to eliminate clearance and maintain tissue integrity, and single gene defects have been shown to confer susceptibility in the murine model [14], [15]. The mIL-8Rh chemokine receptor mutant mice develop acute, septic pyelonephritis with about 50% mortality [4], [12], [16]. They lack the single chemokine receptor for neutrophil chemo-attractants and develop an exaggerated acute inflammatory response, which leads to renal scarring [4], [12], [16]. Based on the susceptibility of the mIL-8Rh mutant mice, we performed a preliminary clinical study of IL-8 receptor expression in APN prone children [5]. Two human receptors interact with IL-8 and related chemokines [17], [18]. CXCR1 is specific for IL-8 and GCP-2 while CXCR2 is more promiscuous [19]. We found that the expression of CXCR1 but not CXCR2 was reduced, suggesting that variant CXCR1 receptor expression might influence human APN susceptibility [5]. A recent family study showed a strong accumulation of APN, further suggesting that APN susceptibility might be inherited [20].
###end p 11
###begin p 12
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
Here we have identified disease-associated polymorphisms and mutations in the CXCR1 gene among APN prone patients, suggesting a novel, genetically determined cause of APN susceptibility.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 14
###begin p 15
###xml 413 421 413 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000825.s001">Table S1</xref>
###xml 1104 1112 1104 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000825.s001">Table S1</xref>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
###xml 59 66 <span type="species:ncbi:9606">infants</span>
###xml 71 79 <span type="species:ncbi:9606">children</span>
###xml 430 438 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">children</span>
###xml 684 692 <span type="species:ncbi:9606">children</span>
###xml 756 764 <span type="species:ncbi:9606">children</span>
###xml 789 797 <span type="species:ncbi:9606">children</span>
###xml 1062 1070 <span type="species:ncbi:9606">patients</span>
Sixty patients with APN and recurrent UTI were studied. 24 infants and children were followed from their first episode of APN, with regular controls at the Department of Pediatrics, Lund University Hospital for a median of 4.5 years. They were <1 to 9 years old (median 1.5 years) at the first infection and 1 to 12 years old (median 6 years) at the time of testing (for clinical data, see Supporting Information Table S1). Seven patients had recurrent pyelonephritis, 23 had an initial episode of pyelonephritis followed by episodes of acute cystitis (n = 7) or asymptomatic bacteriuria (ABU, n = 4). Seven children had a single episode of APN. On 99mTc-DMSA scintigraphy, 19 of the children had renal polar uptake defects typical of pyelonephritis, nine children showed renal scars. All children underwent ultrasound investigation and voiding cystourethography (VCUG) and vesico-ureteric reflux (VUR) was detected in 11/24, of which one had structural abnormalities (double ureters), and one had ureterocele. Hydronephrosis was found in 2/24. The remaining 11 patients had no structural abnormalities (Table S1).
###end p 15
###begin p 16
###xml 22 29 <span type="species:ncbi:9606">patient</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 255 263 <span type="species:ncbi:9606">patients</span>
All but one pediatric patient were Caucasians, and 21 were born to Swedish parents. The father of P8 was from Slovakia, P13 was of Polish origin and P14 was adopted from China. Variants 1 and 2 were detected in patients P8, P13 and P14, but the remaining patients with variants 1 and 2 and those with variants 3, 4 and 5 were born to Swedish parents.
###end p 16
###begin p 17
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Martinell1">[21]</xref>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
Thirty-six patients were adults with a history of childhood APN, who participated in a study of febrile UTI in the 1970ies (median age 4 years) and were followed regularly since then. Between 2002 and 2005, a median of 30 years after the initial UTI episode the patients were reinvestigated [21]. Samples for CXCR1 analysis in this study were obtained, the UTI history was recorded and the kidney status was defined by DMSA scans and Cr51 EDTA clearance. All adult patients were Caucasians.
###end p 17
###begin p 18
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 351 352 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Significant bacteriuria was defined by growth of a single strain (>105 cfu/ml) in a mid-stream urine sample, or by any growth in a supra-pubic bladder aspirate. Pyelonephritis was defined as a febrile infection (>/=38.5degreesC) with significant bacteriuria, C-reactive protein >20 mg/l and lack of symptoms of other infections. ABU was defined as >105 cfu/ml in three consecutive urine samples in an asymptomatic individual.
###end p 18
###begin p 19
###xml 211 218 <span type="species:ncbi:9606">Patient</span>
The studies were approved by the Medical Ethics Committees (IRBs) of the Lund University and the Gothenburg University (LU 236-99, LU 106-02). Informed consent was obtained from all subjects and/or the parents. Patient information was handled according to the HIPPA.
###end p 19
###begin title 20
Controls
###end title 20
###begin p 21
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 236 244 <span type="species:ncbi:9606">children</span>
###xml 249 253 <span type="species:ncbi:9606">boys</span>
###xml 261 266 <span type="species:ncbi:9606">girls</span>
Pediatric controls (n = 26) were enrolled when they attended the Pediatric outpatient clinic or were admitted for elective surgery and were interviewed to ensure that they had no history of UTI or other severe infections. There were 26 children (15 boys and 11 girls) aged 1 to 13 years at the time of sampling (median 6 years). CXCR1 expression was examined in 16 and CXCR1 variants in 26 controls. Adult healthy blood donors (n = 200) from the same geographic area were included as controls to assess the frequency of CXCR1 sequence variants in the background population. Their UTI history had not been penetrated. The pediatric controls were born to Swedish parents.
###end p 21
###begin title 22
Genomic DNA Analysis
###end title 22
###begin p 23
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 296 304 296 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000825.s002">Table S2</xref>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Nickerson1">[22]</xref>
###xml 381 388 <span type="species:ncbi:9606">Patient</span>
Genomic DNA was extracted from peripheral blood neutrophils using proteinase K and phenol-chloroform. Specific primer pairs were designed according to the published genomic DNA sequence for CXCR1 (GenBank accession number: L19592). Primers were chosen based on 3' specificity for the CXCR1 gene (Table S2), in order to avoid mis-amplification of the CXCR1 pseudo-gene (gi 186372). Patient forward and reverse sequences were base called and multi-aligned along with control sequences using PolyPhred [22] and Phrap () respectively.
###end p 23
###begin p 24
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Ahuja1">[23]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Gordon1">[24]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Sherry1">[25]</xref>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 997 1002 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
Sequencing of the amplicons was in both directions, using specific nested primers covering 800 bp upstream of the transcription start to 117 bp downstream of the poly-adenylation (PolyA) signal of the larger of the two mRNA transcripts [23]. In total 5119 bps were amplified from each individual DNA (not including overlaps), resulting in 255.45 kbp for sequence analysis, comparison and single nucleotide polymorphism (SNP) mining. In addition, 1261 bp encompassing a 500 bp fragment upstream of the gene was sequenced to examine possible additional regulatory elements. The sequences were visualized and manually compared using Consed [24]. Known SNPs in dbSNP [25] were tagged to identify novel variants. The CXCR1 promoter (nt -800 to +98) was sequenced using the BigDyetrade mark Terminator Cycle Sequencing v2.0 Ready Reaction Kit and a fluorescence based automated cycle sequencer, ABI PRISMtrade mark 377 (Perkin-Elmer Applied Biosystems) Data were analyzed using BioEdit (T. Hall, ). The CXCR1 gene region (nt -3342 to -2071 and nt -580 to +4318) was sequenced on a MegaBACE 1000 using the DYEnamictrade mark ET dye Terminator Kit (Megabacetrade mark) (Amersham Pharmacia Biotech). Data were analyzed using Polyphred-Phrap and Consed.
###end p 24
###begin title 25
Pyrosequencing
###end title 25
###begin p 26
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000825.s003">Table S3</xref>
Variants in CXCR1 were identified in a Pyrosequencer PSQ 96 using the PSQ 96 SNP Reagent Kit (Pyrosequencing AB, Uppsala, Sweden). The PCR amplification primers for variants 1-5, the nested PCR and pyrosequencing sequencing primers (Table S3) were designed according to the manufacturer's instructions (Pyrosequencing AB; ).
###end p 26
###begin title 27
CXCR1 receptor expression
###end title 27
###begin p 28
###xml 300 303 291 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus1">[5]</xref>
###xml 411 414 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus1">[5]</xref>
###xml 328 335 <span type="species:ncbi:9606">patient</span>
Neutrophils were purified from heparinized whole blood on a Polymorphpreptrade mark density gradient (AXIS-SHIELD, PoC AS) and surface expression of CXCR1 was detected by confocal microscopy (Bio-Rad Laboratories) and quantified by flow cytometry (Coulter, 3000 cells/sample) as previously described [5]. Receptor expression in patient and control samples was related to an adult standard, run at the same time [5].
###end p 28
###begin title 29
Protein extracts and Electrophoretic Mobility Shift Assay (EMSA)
###end title 29
###begin p 30
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Andrews1">[26]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lennartsson1">[27]</xref>
###xml 502 507 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 620 622 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1352 1356 1342 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Heinemeyer1">[28]</xref>
###xml 320 326 <span type="species:ncbi:9913">bovine</span>
Nuclear extracts were prepared from the myeloid cell-line HL60, clone 15, (ATCC No. CRL-1964) [26] with 0.6% NP-40 in the lysis buffer and protease inhibitors (Complete, Roche) in all buffers [27], and stored as aliquots at -80degreesC. Protein concentrations were measured using the DC Protein Assay kit (Bio-Rad) with bovine serum albumin as standard. EMSA was performed using the Gel Shift Assay System (Promega). Double stranded oligonucleotides encompassing the putative RUNX1 binding site in the CXCR1 intron (common allele 5'-CTCTTGTGACCACCACTCAT-3'; SNP1 5'-CTCTTGTGACCAGCACTCAT-3') were end-labeled with [gamma-32P]ATP (Amersham Biotech) to similar specific activities. DNA-protein complexes were separated on 6% polyacrylamide TBE gels (Invitrogen) and visualized by autoradiography in a PhosphorImager, STORM 840 (Amersham Pharmacia Biotech). Unlabeled ds-oligonucleotides at 10- to 100-fold molar excess were used in a competition assay with oligonucleotide 5'-TTGAACGTCACATCTTTAAC-3' as an unspecific competitor, and quantified in a PhosphorImager, STORM 840 (Amersham Pharmacia Biotech). The DNA-binding protein was identified using a RUNX1-specific antibody (AML-1, sc-8563 X) or an irrelevant antibody control (ATF-2, sc-6233 X) (Santa Cruz Biotech). The TFSEARCH database was used to predict the transcription factor binding sites. () [28].
###end p 30
###begin title 31
Real-time PCR
###end title 31
###begin p 32
Total RNA was reverse transcribed using the TaqMan Reverse Transcription Reagents kit and random hexamers or oligo dT primers according to the manufacturer's instructions (Applied Biosystems). Residual genomic DNA was removed using RQ1 RNase-free DNase (Promega). GAPDH (Assay ID Hs99999905_ml, Applied Biosystems), CXCR1 total (assay ID Hs00174146_ml, Applied Biosystems) and CXCR1 large (specifics, see below) transcripts were quantified by real-time PCR using a Corbett Research Rotor-Gene instrument. The assay was designed using Vector NTI (Informax), CXCR1 forward primer 5'-GGTTGTGACAGAGTCAAGGGTGTGT-3' and reverse primer 5'-TGTGCCTCAAGAGACTGTTCTAGCA-3'. The probe 5'-GGCAGCACCTCC TAAGAAGGCA CCT-3' was 5'-end labeled with FAM and 3'-end labeled with Black Hole Quencher 1 (MWG Biotech).
###end p 32
###begin title 33
Luciferase reporter assay
###end title 33
###begin p 34
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 357 365 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000825.s003">Table S3</xref>
We constructed luciferase reporter plasmids by cloning a single copy of the RUNX1 binding motif containing the wild-type (pAML1wt-TK-luc) or the SNP1 (pAML1SNP1-TK-luc) allele upstream of the TK promoter. The plasmids were constructed by cloning the annealed 5'-phosphorylated primer pairs in pGL3-TK-luc vector cleaved with XhoI and BamHI. For primers see Table S3.
###end p 34
###begin p 35
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 314 318 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lennartsson1">[27]</xref>
###xml 480 485 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 763 767 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lennartsson1">[27]</xref>
###xml 97 103 <span type="species:ncbi:9913">bovine</span>
For the luciferase assay, we cultured A498 cells in RPMI 1640 medium supplemented with 10% fetal bovine serum in 6-well culture plates at a density of 5x105 cells per well. The cells were transiently transfected with 3.5 microg of either constructs and co-transfected with 0.10 microg of a plasmid encoding AML-1b [27], (kindly provided by Dr. U. Gullberg, Lund University, Lund, Sweden) by using Lipofectamine 2000 (Invitrogene). A reporter construct (3,5 microg) containing the CXCR1 promoter, exon 1, the intron with a RUNX1 binding motif and exon 2 up to the coding sequence were transiently transfected into the A498 cells. The cells were also co-transfected with 0.10 microg of the plasmid encoding AML-1b and/or with 0.10 microg of a plasmid encoding PU.1 [27], (kindly provided by Dr. U. Gullberg, Lund University, Lund, Sweden). The cells were collected 24 h post-transfection and luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega).
###end p 35
###begin title 36
Statistical Analysis
###end title 36
###begin p 37
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
CXCR1 expression and mRNA levels in pediatric patients and controls and the luciferase assay data was compared by the Mann-Whitney U test, two-sided. The CXCR1 genotype and allele frequency was examined using chi-square Test. The Fishers' exact test was used to calculate the total CXCR1 frequency of in patients with and without VUR compared to pediatric controls. (GraphPad Instat 3 for Macintosh (GraphPad Softwear, Inc.).
###end p 37
###begin title 38
Results
###end title 38
###begin p 39
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Andersen1">[29]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Jakobsson1">[30]</xref>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
###xml 202 210 <span type="species:ncbi:9606">children</span>
###xml 385 393 <span type="species:ncbi:9606">patients</span>
###xml 475 483 <span type="species:ncbi:9606">children</span>
###xml 553 561 <span type="species:ncbi:9606">patients</span>
The different forms of UTI must be distinguished, to appreciate differences in disease susceptibility and to enrich for low frequency genetic factors. The patients in the present study were a subset of children with APN, which is the most severe but least frequent form of UTI. The cumulative APN frequency is about four per cent up to 7 years of age, and only about 1/100 to 1/200 of patients experience recurrent APN after a first APN episode [29], [30]. As a consequence, children with APN and recurrent UTI represent a highly selected subset of all patients with childhood UTI.
###end p 39
###begin p 40
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 454 462 454 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000825.s001">Table S1</xref>
###xml 148 156 <span type="species:ncbi:9606">children</span>
Here, we have examined CXCR1 DNA sequences in two, independent groups of APN prone individuals. The first group consisted of prospectively enrolled children (n = 24) who were followed from their first episode of APN, with regular controls at the Department of Pediatrics, Lund University Hospital. They were <1 to 9 years old (median 1.5 years) at the first infection and 1 to 12 years old (median 6 years) at the time of testing (for clinical data, see Table S1). Pediatric controls of the same age (n = 26) were enrolled when they attended the Lund university hospital for diagnoses unrelated to infection.
###end p 40
###begin p 41
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Martinell1">[21]</xref>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 11 18 <span type="species:ncbi:9606">patient</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
The second patient group was enrolled in a prospective study of febrile UTI in the 1970ies at a median age of 4 years and was prospectively followed [21]. The patients were reinvestigated between 2002 and 2005, a median of 30 years after the initial APN episode, and samples for CXCR1 sequencing were obtained from 36 patients, who had a history of APN and recurrent UTI. Adult healthy blood donors (n = 200) were included, to assess the frequency of CXCR1 sequence variants in the background population.
###end p 41
###begin title 42
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
CXCR1 sequence variants
###end title 42
###begin p 43
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR2</italic>
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Ahuja2">[31]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lloyd1">[32]</xref>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1a</xref>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Ahuja1">[23]</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Sprenger1">[33]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Wilkinson1">[34]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human IL-8 receptor genes CXCR1 and CXCR2 and a homologous pseudo-gene have been mapped to position 2q35 [31], [32]. CXCR1 comprises two exons interrupted by an intron of 1.7 kb and the entire coding sequence is in exon 2 (Fig. 1a). The CXCR1 promoter (-841 to +21) contains a TATA box equivalent, GC-rich motifs that may serve as SP-1 and AP-2 sites, and a GGAA motif serving as a binding site for PU.1, which is a member of the Ets family of transcription factors. Most of the promoter activity is determined by sequences from -56 bp to +50 bp, relative to the transcription start site, with positive regulatory elements located at -126 to +50 bp, and negative regulatory elements located upstream from -126 to about -640 bp. The GGAA binding site for PU.1 is adjacent to the transcription start site at -7 to -4 [23], [33], [34].
###end p 43
###begin title 44
###xml 26 31 <span type="species:ncbi:9606">human</span>
Sequence variation in the human CXCR1 locus.
###end title 44
###begin p 45
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il8ra</italic>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 489 494 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il8rb</italic>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 213 216 <span type="species:ncbi:10116">rat</span>
###xml 377 385 <span type="species:ncbi:9606">patients</span>
###xml 458 461 <span type="species:ncbi:10116">rat</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
###xml 533 538 <span type="species:ncbi:10090">mouse</span>
###xml 567 572 <span type="species:ncbi:9606">human</span>
a, Genomic organization of CXCR1 and positions of genetic variants (Variants 1-5) in the intron, the coding sequence (CDS) and in the 3'untranslation region (3'UTR). b, Comparison of the human CXCR1 gene with its rat ortholog (Il8ra). BLAST homologies indicating strongly conserved regions are shown by the lines connecting the genes. The five CXCR1 variants identified in the patients are all located in or near strongly conserved regions as indicated. The rat was selected, as the human CXCR1 gene does not have an ortholog in the mouse where the equivalent of the human CXCR2 (mIL-8Rh or Il8rb) gene carries out the same function. c, Predicted effects of CXCR1 variants on putative transcription factor binding motifs based on a TRANSFAC search. The transcription factors and % score match of the mutant alleles are shown. d, Variant 1 (enlarged, bold) potentially disrupts the RUNX1 binding motif.
###end p 45
###begin p 46
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 85 92 85 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1a</xref>
###xml 94 102 94 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000825.s002">Table S2</xref>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 329 336 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1a</xref>
###xml 974 981 974 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1a</xref>
Genomic DNA was sequenced using overlapping primers, covering the entire CXCR1 gene (Fig. 1a, Table S2). The nucleotides were numbered relative to their distance from the transcription start site. Five sequence variants were detected in the intron, the coding region of exon 2 and in the 3' untranslated region (3'UTR) of CXCR1 (Fig. 1a). Variant 1 in the intron was a C to G nucleotide substitution at position +217 (3943:L19592), 217 bp from the transcription start site and 317 bases upstream of an ALU element. Variant 2 in exon 2 was a G to C substitution at position +2608 (6334:L19592), resulting in a non-synonymous amino acid change from Serine (Ser) to Threonine (Thr). In the 3'UTR, a C to T transition (variant 3) was detected at position +3081 (6807:L19592) and a G to A transition (variant 4) at position +3082 (6808:L19592). Variant 5 was a G to A transition at position +3665 (7391:L19592) between the Poly(A) signal and the Poly(A) sites of the short mRNA (Fig. 1a).
###end p 46
###begin title 47
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Difference in SNP frequency between patients and controls
###end title 47
###begin p 48
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
###xml 207 214 <span type="species:ncbi:9606">patient</span>
Full-length CXCR1 DNA sequences were obtained from 12 pediatric patients, 35 adult patients with childhood APN and 12 pediatric controls without a history of UTI. In addition, 12 pediatric patients, 1 adult patient, 14 pediatric controls and DNA from 200 adult healthy blood donors was screened for the identified CXCR1 variants, using pyrosequencing with primers specific for each variant.
###end p 48
###begin p 49
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 222 229 222 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000825-t001">Table 1</xref>
###xml 163 171 <span type="species:ncbi:9606">children</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
###xml 383 388 <span type="species:ncbi:9606">child</span>
###xml 613 620 <span type="species:ncbi:9606">patient</span>
###xml 660 668 <span type="species:ncbi:9606">patients</span>
Single base changes in CXCR1 were associated with APN susceptibility in the pediatric population. Sequence variants were detected in 9/24 (37.5%) of the APN prone children, but only in 1/26 (4%) of the pediatric controls (Table 1). Six patients were heterozygous for variants 1 and 2, which were present on 6/48 chromosomes, resulting in minor allele frequencies of 13%. One control child was homozygous for variant 1, resulting in a minor allele frequency of 4%, (2/52 chromosomes). Sequencing of parent DNA showed that variants 1 and 2 were linked. Variants 3, 4 and 5 occurred as heterozygous mutations in one patient each and were unique for the pediatric patients.
###end p 49
###begin title 50
Number of individuals with CXCR1 sequence variants
###end title 50
###begin p 51
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
APN = Acute pyelonephritis. Lund population = Paediatric patients followed from their first infection. Gothenburg = patients with APN in childhood during the 1970ies who were re-examined for this study.
###end p 51
###begin p 52
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000825-t001">Table 1</xref>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 727 734 727 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000825-t002">Table 2</xref>
###xml 736 743 736 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000825-t003">Table 3</xref>
###xml 101 108 <span type="species:ncbi:9606">patient</span>
###xml 464 472 <span type="species:ncbi:9606">patients</span>
###xml 504 512 <span type="species:ncbi:9606">children</span>
In the adults, CXCR1 variants 1 and 2 were detected in 9/36 (25%) and 10/36 (28%), respectively. One patient was homozygous for variant 2, resulting in a minor allele frequency of 15% for variant 2 and 13% for variant 1 in this group. Variants 1 and 2 were detected by pyrosequencing in 16/200 (8%) of controls on 16/400 chromosomes, resulting in a minor allele frequency of 4% (Table 1, p = 0.0056 for variant 1 and p = 0.0018 for variant 2 compared to the adult patients and p = 0.0185 compared to the children with APN, Fischer's exact test, two-sided). The results showed that single base changes in CXCR1 are associated with susceptibility to APN also in adults, thus confirming the disease association of these variants (Table 2, Table 3).
###end p 52
###begin title 53
Frequency of CXCR1 sequence variants 1 and 2
###end title 53
###begin p 54
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">##</sup>
###xml 156 162 156 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a), b)</sup>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
APN = Acute pyelonephritis; n = number of individuals; # nucleotide at position +217 in the intron. ## nucleotide at position +2608 in the coding sequence. a), b) = Chi-square Test, total number of APN prone patients versus total number of controls.
###end p 54
###begin title 55
Allele frequency of CXCR1 sequence variants 1 and 2
###end title 55
###begin p 56
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 124 126 124 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">##</sup>
###xml 180 186 180 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a), b)</sup>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
APN = Acute pyelonephritis; n = number of individuals; N = number of alleles; # nucleotide at position, +217 in the intron. ## nucleotide at position +2608 in the coding sequence. a), b) Fischer's Exact Test, total number of APN prone patients versus total number of controls.
###end p 56
###begin title 57
Putative effects on CXCR1 expression
###end title 57
###begin p 58
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1c</xref>
###xml 260 267 260 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1d</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Meyers1">[35]</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Mao1">[36]</xref>
###xml 652 659 652 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1c</xref>
Variants 1, 3 and 4 were located to sequences with high homology to transcription factor binding motifs, identified by TRANSFAC (Fig. 1c). Variant 1 (217C/G) was in a putative binding site for the runt-related transcription factor 1 (RUNX1, also called AML1) (Fig. 1d), which is required for expression from a number of cell specific enhancers and promoters [35], [36]. The cyclic-AMP-dependent transcription factor ATF-2 (CRE-BP1, compatible transcription factor motif of the common allele) was lost in both the variant 3 (+3081T) and variant 4 (+3082A) -bearing alleles but they retained the potential v-Myb DNA-binding sites from the common allele (Fig. 1c).
###end p 58
###begin p 59
###xml 119 125 119 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Collins1">[37]</xref>
###xml 594 602 594 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The reduction in RUNX1 binding to the variant 1 sequence was confirmed by electrophoretic mobility shift assay (EMSA) (Fig. 2). Nuclear extracts from the HL60 cell-line were used. HL60 cells are promyelocytic leukemic cells and a significant percentage of the cultured cells (10-12%) differentiate spontaneously into mature neutrophils [37]. The HL60 cells are thus neutrophil like and are an accepted model to study neutrophil cells. In addition, they express high amounts of the transcription factor AML1. Mature neutrophils, in contrast, are end stage cells, which are difficult to maintain in vitro for more than a few hours and which are difficult to transfect. Furthermore, the concentration of proteolytic enzymes is very high and it is difficult to isolate intact nuclear proteins.
###end p 59
###begin title 60
Effects of CXCR1 sequence variants on transcription.
###end title 60
###begin p 61
###xml 809 810 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1211 1212 1209 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 1268 1273 1266 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 1314 1319 1312 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
a, EMSA, showing the binding to the putative RUNX1 oligonucleotides of proteins in a HL60 cell nuclear extract. Binding (arrow) was stronger to the wild type (lane 2) than to the variant 1 oligonucleotide (lane 4). Lanes 1 and 3 are probes without proteins. b, Competitive inhibition of binding by cold intact probe (100-fold excess, lane 3), but not by unspecific probe (100x excess, lane 4). A super-shifted band, indicated by the arrow, was obtained with anti-RUNX1 (lane 5) but not with control antibody (anti ATF-2) (lane 6). Hatched lines indicate removed excess lanes. c, Inhibition of specific wild-type binding by unlabeled wt probe (10x-100x, lanes 2-5) and reduced efficiency of competition with unlabelled SNP1 probe (10x-100x, lane 6-9). d, The inhibition of the DNA-protein interaction in Panel c was quantified in a Phosphor Imager. e, Effect of SNP1 on RUNX1-dependent transcriptional transactivation. Allelic differences in relative luciferase activity in pAML1 (wt/SNP1)-TK-luc transfected A498 cells with or without co-transfection with an AML-1b expression vector. Data show the mean +/- SEMs of three separate experiments done in duplicate. *P = 0.0104 and **P = 0.1199 by the Mann-Whitney U test, two-tailed. f, RUNX1 and PU.1 interacts with the CXCR1 promoter in transfected A498 cells. The CXCR1 promoter activity was quantified using luciferase. The signal was enhanced by co-transfection with the AML1b (RUNX1) and PU.1 expression plasmids.
###end p 61
###begin p 62
###xml 291 298 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2a</xref>
###xml 455 462 455 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2b</xref>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2b</xref>
###xml 676 683 676 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2c</xref>
###xml 722 729 722 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2c</xref>
###xml 807 814 807 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2d</xref>
HL60 cell nuclear extracts were incubated with oligonucleotide probes encompassing the putative RUNX1 binding site, and complex formation was detected by gel electrophoresis. There was a significant decrease in RUNX1 binding to the mutated sequence compared to the common allele (wt-probe) (Fig. 2a, lanes 2 and 4). The specificity was confirmed by competition with cold common allele probe at 100 fold molar excess, but an unrelated probe had no effect (Fig. 2b, lane 3 respective 4). The bound protein was identified as RUNX1 by specific antibody (Fig. 2b, lane 5) in a super-shift assay and the specificity was confirmed by competitive inhibition with unlabelled wt-probe (Fig. 2c, lane 2-5) or SNP1 (variant 1) probe (Fig. 2c, lane 6-9). Variant 1 was a less efficient inhibitor than the common allele (Fig. 2d).
###end p 62
###begin p 63
###xml 618 625 618 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2e</xref>
###xml 806 811 806 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 868 873 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 941 946 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 1115 1122 1115 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g002">Fig. 2f</xref>
###xml 358 363 <span type="species:ncbi:9606">human</span>
To examine the effect of variant 1 on RUNX1 transcriptional transactivation, we constructed a luciferase reporter carrying the putative RUNX1 binding motif with the variant 1 (pAML1SNP1-TK-luc) or the wild type allele (pAML1wt-TK-luc) and the luciferase activity was used as a read out of RUNX1-dependent transcription. To control transcription, we selected human kidney epithelial cells (A498), which lack the RUNX1 transcription factor. RUNX1 dependent transcription was artificially induced, by co-transfecting the cells with an AML-1b expression vector and as a result, RUNX1 dependent transcription was enhanced (Fig. 2e). In this RUNX1 dependent assay, the luciferase activity from the mutant allele was reduced compared to the wild type allele, thus supporting the hypothesis that variant 1 reduces CXCR1 transcription. Further evidence of RUNX1 involvement in CXCR1 transcription was obtained by co-transfection of A498 cells with a CXCR1 promoter reporter plasmid and vectors encoding RUNX1 and PU.1. The promoter was fully functional, and both RUNX1 and PU.1 were required to enhance luciferase activity (Fig. 2f).
###end p 63
###begin title 64
Aberrant CXCR1 mRNA processing associated with variant 5
###end title 64
###begin p 65
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Ahuja1">[23]</xref>
###xml 206 216 206 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g001">Fig. 1a, b</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Decker1">[38]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Conne1">[39]</xref>
###xml 591 598 <span type="species:ncbi:9606">patient</span>
CXCR1 has two alternative poly(A) sites and a long and a short transcript are formed [23]. Variant 5 caused a 3' G to A transition at position +3665, between the first poly(A) signal and the poly(A) sites (Fig. 1a, b). A similar polymorphism in the prothrombin gene has been shown to increase the efficiency of mRNA 3'-processing [38], [39]. If variant 5 had a similar effect, the levels of the long CXCR1 transcripts would be reduced. The long and total CXCR1 transcripts were quantified by RT-PCR using cDNA reverse transcribed with random hexamers or oligo dT primers. The mRNAs from the patient carrying variant 5 and the mother with the same mutation contained reduced levels of the CXCR1 large transcript compared to the control, thus confirming the predicted effect of variant 5, suggesting that this mutation might create a more efficient cleavage site and thus reduce the amount of large CXCR1 mRNA (data not shown).
###end p 65
###begin title 66
Vesico-ureteric reflux
###end title 66
###begin p 67
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 324 331 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000825-t004">Table 4</xref>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000825-t004">Table 4</xref>
###xml 593 600 593 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000825-t004">Table 4</xref>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 223 231 <span type="species:ncbi:9606">children</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
###xml 430 438 <span type="species:ncbi:9606">children</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 703 711 <span type="species:ncbi:9606">patients</span>
Reflux is known to predispose to acute pyelonephritis and renal scarring. The relative contribution to APN susceptibility of vesico-ureteric reflux (VUR) and CXCR1 sequence variation was therefore examined in the APN prone children, where 11/24 had VUR and two had structural abnormalities (ureterocele and double ureters) (Table 4). The patients without VUR had a higher frequency of CXCR1 sequence variants (7/13, 54%) than the children with VUR (2/11, 18%, Table 4). The group without VUR was significantly different from the controls (p = 0.0007) but the patients with VUR were not (n.s., Table 4). The results suggest that CXCR1 sequence variation and VUR are independent risk factors in APN-prone patients.
###end p 67
###begin title 68
CXCR1 sequence variants related to reflux
###end title 68
###begin p 69
###xml 64 72 <span type="species:ncbi:9606">patients</span>
The frequency of variants was significantly higher in APN prone patients without VUR than in paediatric controls.
###end p 69
###begin p 70
###xml 30 38 <span type="species:ncbi:9606">patients</span>
* p = 0.0345 for variant 1 in patients without VUR compared to pediatric controls
###end p 70
###begin p 71
###xml 31 39 <span type="species:ncbi:9606">patients</span>
** p = 0.0087 for variant 2 in patients without VUR compared to pediatric controls
###end p 71
###begin p 72
###xml 28 36 <span type="species:ncbi:9606">patients</span>
p = 0.2053 for variant 1 in patients with VUR compared to pediatric controls
###end p 72
###begin p 73
###xml 28 36 <span type="species:ncbi:9606">patients</span>
p = 0.0826 for variant 2 in patients with VUR compared to pediatric controls
###end p 73
###begin p 74
###xml 33 41 <span type="species:ncbi:9606">patients</span>
p = 0.0007 for total variants in patients without VUR compared to pediatric controls
###end p 74
###begin p 75
Fischers exact test, two sided;
###end p 75
###begin p 76
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
 = number of individuals with variant CXCR1 sequences
###end p 76
###begin title 77
###xml 42 50 <span type="species:ncbi:9606">children</span>
Low CXCR1 surface expression in APN-prone children
###end title 77
###begin p 78
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g003">Fig. 3a</xref>
###xml 388 395 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000825-g003">Fig. 3b</xref>
###xml 609 610 609 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 729 734 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 736 739 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus1">[5]</xref>
###xml 88 95 <span type="species:ncbi:9606">patient</span>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
###xml 356 363 <span type="species:ncbi:9606">patient</span>
###xml 402 409 <span type="species:ncbi:9606">patient</span>
###xml 741 749 <span type="species:ncbi:9606">Patients</span>
###xml 836 844 <span type="species:ncbi:9606">patients</span>
We obtained peripheral blood neutrophils during an infection free interval or while the patient received antibiotic prophylaxis. By confocal microscopy (Fig. 3a) we observed that the surface staining for CXCR1 was markedly reduced in the patients compared to the controls. The difference in CXCR1 expression was quantified by flow cytometry analysis of 23 patient and 16 control samples (Fig. 3b). The patient CXCR1 expression showed a mean of -1,44, range -6.52-(1.04) compared to the standard while the controls showed a mean of 0.28, range -0.73-(2.15), (p<0.0001 for the group-wise analysis, Mann-Whitney U test, two-tailed). The results confirmed and extended data on CXCR1 expression from the preliminary study by Frendeus et al. [5]. Patients 1-12 in that study had CXCR1 levels of -1.33, range -6.52-(1.04). The newly recruited patients 13-21 and 23-24 in this study expressed a mean of -1.57, range -2.76-(0.63) compared to the standard.
###end p 78
###begin title 79
###xml 62 70 <span type="species:ncbi:9606">children</span>
Low CXCR1 expression on neutrophils from pyelonephritis prone children compared to pediatric controls.
###end title 79
###begin p 80
###xml 63 70 <span type="species:ncbi:9606">patient</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 242 250 <span type="species:ncbi:9606">patients</span>
a, Confocal microscopy images of individual samples from eight patient and controls, using a monoclonal anti-human CXCR1 primary and a FITC conjugated, anti-mouse secondary antibody. b, Quantification by flow cytometry of CXCR1 expression in patients (white peaks) and controls (black peaks).
###end p 80
###begin title 81
Discussion
###end title 81
###begin p 82
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Andersen1">[29]</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Kunin1">[6]</xref>
###xml 426 429 426 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hodson1">[8]</xref>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Ransley1">[9]</xref>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Lomberg1">[10]</xref>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 16 24 <span type="species:ncbi:9606">children</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
###xml 699 707 <span type="species:ncbi:9606">patients</span>
###xml 760 768 <span type="species:ncbi:9606">patients</span>
###xml 812 820 <span type="species:ncbi:9606">patients</span>
###xml 1086 1094 <span type="species:ncbi:9606">children</span>
A subset of all children with UTI are APN prone, and risk to develop recurrent infections and kidney damage [29]. There have been many attempts to identify the host factors, which predispose them to infection. Reflux, blood groups, social and environmental variables have been discussed but molecular markers have not been identified until mIL-8Rh mutant mice were shown to develop APN with bacteremia and renal scarring [6], [8], [9], [10]. Here we show that variation in the human IL-8 receptor gene may influence APN susceptibility and propose a mechanism how the variant alleles may suppress innate immunity in the urinary tract. Five CXCR1 sequence variants were detected in carefully selected patients with APN. Three new 3' mutations were unique to the patients and two known variants were more common in patients than in controls, supporting a disease association. Variant 1 reduced the efficiency of RUNX1 dependent transcription and another three variants were located to transcription factor binding sites. As expected, CXCR1 expression was markedly reduced in the APN prone children compared to controls. The results suggest that CXCR1 variants may render individuals UTI-prone by lowering CXCR1 expression and by incapacitating the neutrophil-dependent host defense against UTI.
###end p 82
###begin p 83
###xml 540 543 540 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Hang1">[4]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Frendeus2">[12]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Svensson1">[16]</xref>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM-1</italic>
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Gbadegesin1">[40]</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Sun1">[41]</xref>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Springer1">[42]</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Agace1">[43]</xref>
###xml 1118 1122 1118 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Agace1">[43]</xref>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Pober1">[44]</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
Innate immunity controls the resistance to UTI and neutrophils are needed for bacterial clearance from infected tissues. The chemokine receptor deficiency in mIL-8Rh knock out mice incapacitates neutrophils by delaying their migration into the kidneys and their exit from the tissues across the mucosal barrier. In addition, the receptor is needed for neutrophil activation and phagocytosis and killing of bacteria is impaired in knock out mice. As a result, bacteria persist in the kidneys, and the trapped neutrophils destroy the tissues [4], [12], [16]. Similar conclusions were drawn in a recent study, where polymorphisms in the ICAM-1 gene were shown to protect against renal scarring following UTI by decreasing the number of neutrophils and thereby the inflammatory host response [40]. ICAM-1 is expressed on endothelial cells as well as on kidney and bladder epithelial cells and acts as a counter-receptor for Mac-1 [41]. ICAM-1 expression is increased on the cytokine-activated endothelium [42] and on infected epithelium [43] and is involved in the endothelial and epithelial transmigration of neutrophils [43], [44]. These observations illustrate the delicate balance between the protective and destructive aspects of the neutrophil-dependent defense against UTI.
###end p 83
###begin p 84
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Wilkinson1">[34]</xref>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Mao1">[36]</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Anderson1">[45]</xref>
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 725 733 725 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 982 987 982 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD1</italic>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Prokunina1">[46]</xref>
###xml 1082 1089 1082 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4</italic>
###xml 1128 1132 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Tokuhiro1">[47]</xref>
###xml 1134 1138 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Yamada1">[48]</xref>
###xml 1247 1251 1247 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Helms1">[49]</xref>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 1026 1034 <span type="species:ncbi:9606">patients</span>
###xml 1093 1101 <span type="species:ncbi:9606">patients</span>
The UTI associated CXCR1 variant 1 was shown to reduce RUNX1 binding to the putative intronic binding site. Furthermore, transfection experiments showed that transcription of the mutant allele is reduced, suggesting that variant 1 reduces CXCR1 transcription. RUNX1 activates transcription through protein-protein interactions with the Ets family of transcription factors, including PU.1, which is a regulator of CXCR1 expression [34], [36]. Neutrophils from PU.1-null mice fail to terminally differentiate and their neutrophils fail to respond to CXCL8, indicating that functional receptors are not expressed when this transcription factor is absent [45]. The importance of PU.1 for CXCR1 transcription was supported by our in vitro transfection studies showing an interaction between transcription factors AML1b (RUNX1) and PU.1 promoted transcription in a luciferase reporter assay. Reduced RUNX1 binding caused by intronic SNPs has been proposed to cause aberrant regulation of PDCD1 (the programmed cell death 1 gene) in patients with systemic lupus erythematosus [46], and of SLC22A4 in patients with rheumatoid arthritis [47], [48]. In addition, increased susceptibility to psoriasis was associated with a loss of inter-genic RUNX1 binding [49].
###end p 84
###begin p 85
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Gehring1">[50]</xref>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 631 639 <span type="species:ncbi:9606">patients</span>
###xml 738 746 <span type="species:ncbi:9606">patients</span>
###xml 888 895 <span type="species:ncbi:9606">patient</span>
The two additional 3'variants (3 and 4) were also proposed to influence transcription, based on TRANSFAC searches, which identified putative transcription factor binding sites. Variant 5 was associated with reduced levels of the large CXCR1 transcript, suggesting that this mutation might create a more efficient cleavage site and thus reduce the amount of large CXCR1 mRNA. A similar mutation was shown to create a more efficient mRNA cleavage site in the pro-thrombin gene where more efficient processing of the transcript leads to higher pro-thrombin levels and a higher risk of thrombosis [50]. In addition, there were several patients with low CXCR1 expression but without variation in the CXCR1 gene. Thus, even if the frequency of patients with single base changes was high, there must be additional mechanisms, which control CXCR1 expression, and which may be polymorphic in this patient group.
###end p 85
###begin p 86
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Artifoni1">[51]</xref>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000825-Smithson1">[52]</xref>
###xml 1024 1029 1024 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR1</italic>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 246 253 <span type="species:ncbi:9606">patient</span>
###xml 683 691 <span type="species:ncbi:9606">patients</span>
###xml 793 801 <span type="species:ncbi:9606">patients</span>
###xml 975 983 <span type="species:ncbi:9606">patients</span>
###xml 1184 1192 <span type="species:ncbi:9606">patients</span>
###xml 1364 1372 <span type="species:ncbi:9606">patients</span>
###xml 1554 1562 <span type="species:ncbi:9606">patients</span>
Longitudinal clinical studies must be performed, to reliably identify those patients, who are susceptible to recurrent APN. Such protocols were used in the present study, in two separate geographic sites, resulting in two well-defined, APN-prone patient populations. We found an increased frequency of CXCR1 sequence variants in both groups. The pediatric group had been followed from the first known febrile UTI episode by our clinical team and the adults were followed regularly from their first febrile UTI episode for a median of 30 years. The need for stringent clinical definitions is illustrated by a recent report, which failed to show a significant increase in variant 2 in patients with DMSA proven kidney infections [51]. In a second study, low CXCR1 expression was detected in 3/9 patients with childhood APN and two had SNPs in exon 2, but the numbers were small and no conclusions were drawn [52]. The stringent clinical follow up and large number of APN prone patients probably explains the high frequency of CXCR1 variants and of reduced CXCR1 expression. On the other hand, the complicated clinical procedures illustrate the need for markers, which identify the risk patients already in connection with their first UTI episode. If this were possible, proper therapeutic interventions might be made and invasive diagnostic procedures restricted to patients at high risk, while those of lower risk might be spared. We are hopeful that the results of this study will be useful and that they might stimulate attempts to identify susceptible patients who might benefit from more intense diagnostic surveillance and therapeutic intervention.
###end p 86
###begin title 87
Supporting Information
###end title 87
###begin p 88
###xml 10 18 <span type="species:ncbi:9606">patients</span>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
APN prone patients. Clinical data of the APN-prone pediatric patients included in the study.
###end p 88
###begin p 89
(0.05 MB PDF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
Amplification and sequencing primers used. Summary of the primers used for CXCR1 amplification and sequencing.
###end p 91
###begin p 92
(0.03 MB PDF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
Pyrosequencing CXCR1 genotyping primers and Vector construction. Summary of the primers used for genotyping by pyrosequencing and vector construction.
###end p 94
###begin p 95
(0.04 MB PDF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
We thank Birgitta Gullstrand and Gertrud Hellmer at the Department of MIG and Dr Waleed Abu Al-Soud at the Department of Medical Microbiology, Institute of Laboratory Medicine, Lund University, Sweden for technical assistance.
###end p 97
###begin title 98
References
###end title 98
###begin article-title 99
Ultrastructural localization of capsules, cell wall polysacharide, cell wall proteins, and F antigen in pneumococci.
###end article-title 99
###begin article-title 100
Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria.
###end article-title 100
###begin article-title 101
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice that affect the susceptibility to Gram-negative infections.
###end article-title 101
###begin article-title 102
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis.
###end article-title 102
###begin article-title 103
###xml 109 114 <span type="species:ncbi:9606">human</span>
Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart.
###end article-title 103
###begin article-title 104
Urinary Tract Infections: Detection, Prevention, and Management: Lippincott Williams and Wilkins
###end article-title 104
###begin article-title 105
###xml 57 62 <span type="species:ncbi:9606">women</span>
Natural history of recurrent urinary tract infections in women.
###end article-title 105
###begin article-title 106
The pathogenesis of reflux nephropathy (chronic atrophic pyelonephritis).
###end article-title 106
###begin article-title 107
Reflux and renal scarring.
###end article-title 107
###begin article-title 108
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Correlation of P blood group phenotype, vesicoureteral reflux and bacterial attachment in patients with recurrent pyelonephritis.
###end article-title 108
###begin article-title 109
Genetic factors in host resistance to urinary tract infection.
###end article-title 109
###begin article-title 110
Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis.
###end article-title 110
###begin article-title 111
HLA-B12 as a genetic marker for vesicoureteric reflux?
###end article-title 111
###begin article-title 112
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice.
###end article-title 112
###begin article-title 113
The 'innate' host response protects and damages the infected urinary tract.
###end article-title 113
###begin article-title 114
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Natural history of renal scarring in susceptible mIL-8Rh-/- mice.
###end article-title 114
###begin article-title 115
###xml 41 46 <span type="species:ncbi:9606">human</span>
Structure and Functional expression of a human interleukin-8 receptor.
###end article-title 115
###begin article-title 116
###xml 51 56 <span type="species:ncbi:9606">human</span>
Cloning of complementary DNA encoding a functional human interleukin-8 receptor.
###end article-title 116
###begin article-title 117
Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
###end article-title 117
###begin article-title 118
Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection.
###end article-title 118
###begin article-title 119
Urinary infection, reflux and renal scarring in females continuously followed for 13-38 years.
###end article-title 119
###begin article-title 120
PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.
###end article-title 120
###begin article-title 121
###xml 65 70 <span type="species:ncbi:9606">human</span>
Comparison of the genomic organization and promoter function for human interleukin-8 receptors A and B.
###end article-title 121
###begin article-title 122
Consed: a graphical tool for sequence finishing.
###end article-title 122
###begin article-title 123
dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation.
###end article-title 123
###begin article-title 124
A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.
###end article-title 124
###begin article-title 125
###xml 44 49 <span type="species:ncbi:9606">human</span>
AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein.
###end article-title 125
###begin article-title 126
Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL.
###end article-title 126
###begin article-title 127
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 83 89 <span type="species:ncbi:562">E.coli</span>
Studies of urinary tract infections in infancy and childhood. VII. The relation of E.coli antibody in pyelonephritis as measured by homologous and common (Kunin) antigens.
###end article-title 127
###begin article-title 128
Minimum incidence and diagnostic rate of first urinary tract infection.
###end article-title 128
###begin article-title 129
###xml 27 32 <span type="species:ncbi:9606">human</span>
Molecular evolution of the human interleukin-8 receptor gene cluster.
###end article-title 129
###begin article-title 130
###xml 66 71 <span type="species:ncbi:9606">human</span>
Assignment of genes for interleukin-8 receptors (IL8R) A and B to human chromosome band 2q35.
###end article-title 130
###begin article-title 131
###xml 79 84 <span type="species:ncbi:9606">human</span>
Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene.
###end article-title 131
###begin article-title 132
PU.1 regulates the CXCR1 promoter.
###end article-title 132
###begin article-title 133
The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation.
###end article-title 133
###begin article-title 134
Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias.
###end article-title 134
###begin article-title 135
###xml 28 33 <span type="species:ncbi:9606">human</span>
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
###end article-title 135
###begin article-title 136
Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts.
###end article-title 136
###begin article-title 137
The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?
###end article-title 137
###begin article-title 138
Association between ICAM-1 Gly-Arg polymorphism and renal parenchymal scarring following childhood urinary tract infection.
###end article-title 138
###begin article-title 139
###xml 118 122 <span type="species:ncbi:10116">rats</span>
Expression and significance of ICAM-1 and its counter receptors LFA-1 and Mac-1 in experimental acute pancreatitis of rats.
###end article-title 139
###begin article-title 140
Adhesion receptors of the immune system.
###end article-title 140
###begin article-title 141
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli induce trans-uroepithelial neutrophil migration by an ICAM-1 dependant mechanism.
###end article-title 141
###begin article-title 142
The role of endothelial cells in inflammation.
###end article-title 142
###begin article-title 143
Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent.
###end article-title 143
###begin article-title 144
###xml 104 110 <span type="species:ncbi:9606">humans</span>
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.
###end article-title 144
###begin article-title 145
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis.
###end article-title 145
###begin article-title 146
SLC22A4 and RUNX1: identification of RA susceptible genes.
###end article-title 146
###begin article-title 147
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.
###end article-title 147
###begin article-title 148
Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia.
###end article-title 148
###begin article-title 149
Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis.
###end article-title 149
###begin article-title 150
###xml 73 78 <span type="species:ncbi:9606">women</span>
Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.
###end article-title 150
###begin p 151
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 151
###begin p 152
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from the Swedish Medical Research Council (grants no. -07934, 14577, 14578); The Royal Physiographic Society and The Medical Faculty, Lund University. The sequencing efforts were supported by the Genome Project of the Foundation for Strategic Research and the Beijer Foundation. Catharina Svanborg was a recipient of the Bristol-Myers Squibb, unrestricted grant and Gabriela Godaly is the recipient of Junior Research Scientist Grant from the Swedish Medical Research Council.
###end p 152

